Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1912-32-9 | MDL No. : | MFCD00041257 |
Formula : | C5H12O3S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | LFLBHTZRLVHUQC-UHFFFAOYSA-N |
M.W : | 152.21 | Pubchem ID : | 15953 |
Synonyms : |
|
Num. heavy atoms : | 9 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 1.0 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 36.2 |
TPSA : | 51.75 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.59 cm/s |
Log Po/w (iLOGP) : | 1.75 |
Log Po/w (XLOGP3) : | 0.9 |
Log Po/w (WLOGP) : | 1.84 |
Log Po/w (MLOGP) : | 0.72 |
Log Po/w (SILICOS-IT) : | 0.21 |
Consensus Log Po/w : | 1.09 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.09 |
Solubility : | 12.5 mg/ml ; 0.0819 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.57 |
Solubility : | 4.08 mg/ml ; 0.0268 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.52 |
Solubility : | 4.63 mg/ml ; 0.0304 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.57 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
98% | Stage #1: With sodium methylate In methanol at 0℃; for 1 h; Stage #2: for 6 h; |
151 g of 99percent 1,2'-benzisothiazolin-3-one(1 mol) was added to 257 g of methanol, and 193 g of a 28percent solution of sodium methoxide in methanol (sodium methanol) was added dropwise, followed by stirring and stirring for 1 hour to 0 0C. 160 g of n-butyl methanesulfonate Mol, the reaction was carried out for 6 hours, the solvent was distilled off under reduced pressure, 300 g of toluene was added, washed twice with water, and toluene was recovered under reduced pressure to give 2-butyl-1,2-benzisothiazoline -3-carboxylate (HPLC> 98percent) in a yield of 98percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | With pyridine In dichloromethane at 0 - 20℃; for 6 h; | To a solution of butanol (500 mg, 6.7 mmol) in dry CH2Cl2 (10 mL) pyridine (0.82 mL, 10.1 mmol) and MsCl (0.78 mL, 10.1 mmol) were added in sequence. The reaction was stirred at 0°C and allowed to warm to temperature. After 6 h, the mixture was quenched with MeOH and concentrated, then diluted with ethyl acetate (50 mL), washed with 1M HCl (10 mL), saturated NaHCO3 (10 mL) and saturated brine (10 mL), the organic layer was dried over anhydrous Na2SO4 and concentrated. The resulting residue was purified by silica gel column chromatography to afford compound 2 as colorless oil (0.94 g, 92percent). 1H NMR (400 MHz,CDCl3) δ 4.24 (t, J = 13.2, 6.4 Hz, 2H), 3.01 (s, 3H), 1.76–1.72 (m, 2H), 1.48–1.42 (m, 2H), 0.96 (t, J = 12.8, 7.6 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 69.99,37.30, 31.05, 18.67, 13.48.HRMS(ESI) calcd for [C5H12SO3 +Na]+ 175.0405, found 175.0401 |
91% | With N-ethyl-N,N-diisopropylamine In dichloromethane at -5 - 0℃; for 0.5 h; | A) Methanesulfonic acid butyl ester. n-Butanol (6.7 g, 8.2 mL, 0.090 mol) was dissolved in 30 mL anhydrous methylene chloride and diisopropylethylamine (19.4 g, 26.1 mL, 0.150 mol) was added. The solution was cooled to -5 0C and methanesulfonyl chloride (11.4 g, 7.74 mL, 0.100 mol) was added dropwise followed by stirring for 0.5 hours at -5 to 00C. After 0.5 hours, the reaction was quenched with ice cold water. The crude mixture was washed with ice cold water, cold 10 percent hydrochloric acid, followed by cold water and then cold sodium bicarbonate solution and finally with cold brine. The organic phase was dried over anhydrous magnesium sulfate and the solvent was removed by evaporation. The sub-title product (13.8 g, 91percent) was extracted as slightly brownish liquid after removal of solvents in vacua. The sub-title product was used in the next step without further purification.1H NMR (400 MHz, chloroforn>d as solvent and internal reference) δ (ppm) 4.19 (t, 2H, J = 6.5 Hz), 2.96 (s, 3H), 1.69 (m, 2H), 1.40 (m, 2H), 0.91 (t, 2H, J- 7.3 Hz). |
90% | With triethylamine In dichloromethane at -10 - 20℃; | Methanesulfonyl chloride (15.45 g, 0.13 mol) was added to a mixture of n-butanol (10 g, 0.13 mol), triethylamine (26.3 g, 0.26 mol) and dichloromethane (150 g) at 10 C. After being stirred at room temperature overnight, water (100 g) was added to the reaction mixture and the layers were separated. The organic layer was concentrated in vacuo at room temperature. This gave 18 g (90percent) of the title mesylate as an oil. 1H NMR analysis supports the stated structure. *Previously described in J. Amer. Chem. Soc. 1933,55, 345-349. |
[ 16427-44-4 ]
2-Methoxyethyl methanesulfonate
Similarity: 0.76
[ 186204-35-3 ]
(R,R)-1,2-Bis(Methanesulphonyloxymethyl)cyclohexane
Similarity: 0.85
[ 16427-44-4 ]
2-Methoxyethyl methanesulfonate
Similarity: 0.76